Symbol="AVIR"
AssetType="Common Stock"
Name="Atea PharmaceuticalsÂ Inc"
Description="Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts."
CIK="1593899"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="125 SUMMER STREET, 16TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="285643000"
EBITDA="-129687000"
PERatio="None"
PEGRatio="None"
BookValue="7.41"
DividendPerShare="0"
DividendYield="0"
EPS="-1.23"
RevenuePerShareTTM="2.31"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.12"
ReturnOnEquityTTM="-0.168"
RevenueTTM="192180000"
GrossProfitTTM="-81936000"
DilutedEPSTTM="-1.23"
QuarterlyEarningsGrowthYOY="2.641"
QuarterlyRevenueGrowthYOY="2.952"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.903"
PriceToBookRatio="0.551"
EVToRevenue="58.97"
EVToEBITDA="-9.68"
Beta="0.176"
num_52WeekHigh="8.72"
num_52WeekLow="2.94"
num_50DayMovingAverage="3.848"
num_200DayMovingAverage="4.128"
SharesOutstanding="83399000"
DividendDate="None"
ExDividendDate="None"
symbol="AVIR"
open="3.38"
high="3.46"
low="3.35"
price="3.41"
volume="236017.00"
latest_trading_day="2023-08-08"
previous_close="3.40"
change="0.01"
change_percent="0.2941%"
aroon_positive_momentum_days="54"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="641314"
Change_recent_avg="-0.01"
Delta_recent_avg="0.17"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="1127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_negative_thumbnail_id_2="1133"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="665"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0043.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
